Nyxoah SA Net Common Equity Issued/Repurchased 2021-2025 | NYXH
Nyxoah SA net common equity issued/repurchased from 2021 to 2025. Net common equity issued/repurchased can be defined as the net dollar amount of transactions to issue and repurchase common stock.
| Nyxoah SA Annual Net Common Equity Issued/Repurchased (Millions of US $) |
|
|---|---|
| 2024 | $75 |
| 2023 | $20 |
| 2022 | $0 |
| 2021 | $92 |
| 2020 | $118 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.214B | $0.005B |
| Nyxoah SA is a medical technology company. It focused on the development and commercialization of solutions to treat Obstructive Sleep Apnea. Nyxoah SA is based in Belgium. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $39.499B | 54.56 |
| Hims & Hers Health (HIMS) | United States | $14.471B | 150.35 |
| Tempus AI (TEM) | United States | $11.278B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.503B | 70.35 |
| IRhythm Technologies (IRTC) | United States | $4.501B | 0.00 |
| Privia Health (PRVA) | United States | $3.050B | 208.50 |
| Enovis (ENOV) | United States | $2.060B | 11.48 |
| Clover Health Investments (CLOV) | United States | $1.807B | 0.00 |
| Schrodinger (SDGR) | United States | $1.722B | 0.00 |
| Phreesia (PHR) | United States | $1.510B | 0.00 |
| Omnicell (OMCL) | United States | $1.310B | 23.11 |
| Azenta (AZTA) | United States | $1.258B | 58.45 |
| 10x Genomics (TXG) | United States | $1.148B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.620B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.581B | 0.00 |
| Talkspace (TALK) | United States | $0.499B | 149.00 |
| Veradigm (MDRX) | United States | $0.455B | 0.00 |
| Claritev (CTEV) | United States | $0.450B | 0.00 |
| Standard BioTools (LAB) | United States | $0.410B | 0.00 |
| TruBridge (TBRG) | United States | $0.376B | 834.67 |
| Health Catalyst (HCAT) | United States | $0.283B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.197B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.142B | 0.00 |
| Pulmonx (LUNG) | United States | $0.138B | 0.00 |
| American Well (AMWL) | United States | $0.116B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.099B | 0.00 |
| CareCloud (CCLD) | United States | $0.089B | 3.39 |
| Outset Medical (OM) | United States | $0.070B | 0.00 |
| 111 (YI) | China | $0.067B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.059B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.057B | 0.00 |
| HeartBeam (BEAT) | United States | $0.052B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.042B | 0.00 |
| Zhongchao (ZCMD) | China | $0.032B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.013B | 0.00 |
| Precipio (PRPO) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |